Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and

Tomoyuki Kawakita1, Katsuya Shiraki, Yutaka Yamanaka

  • 1First Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507, Japan.

Insights

TNF-like weak inducer of apoptosis (TWEAK) promotes hepatocellular carcinoma (HCC) cell proliferation via autocrine and paracrine signaling. TWEAK also influences tumor angiogenesis by affecting endothelial cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • TNF-like weak inducer of apoptosis (TWEAK) is a TNF family member with diverse biological activities.
  • TWEAK expression is observed in various human tissues.
  • The role of TWEAK in human hepatocellular carcinomas (HCCs) requires further investigation.

Purpose of the Study:

  • To investigate TWEAK sensitivity, expression, and its physiological role in human HCCs.
  • To determine TWEAK's impact on HCC cell proliferation and signaling pathways.
  • To assess TWEAK's influence on tumor-related angiogenesis.

Main Methods:

  • Detection of TWEAK receptor in HCC cell lines.
  • Assessment of TWEAK's effect on HCC cell proliferation and NF-κB activation.
  • Evaluation of TWEAK's role in human umbilical vein endothelial cell (HUVEC) proliferation, IL-8, and MCP-1 secretion.
  • Inhibition of HUVEC tube formation using anti-TWEAK antibody.

Main Results:

  • TWEAK receptor was detected in four HCC cell lines.
  • TWEAK significantly promoted HCC cell proliferation and induced NF-κB activation.
  • HCC cells constitutively express TWEAK, with soluble TWEAK detected in culture medium.
  • TWEAK promoted HUVEC proliferation and induced IL-8 and MCP-1 secretion.
  • Anti-TWEAK antibody inhibited endothelial cell tube formation.

Conclusions:

  • TWEAK plays a critical role in HCC cellular proliferation through autocrine and paracrine mechanisms.
  • TWEAK modulates tumor-related angiogenesis by affecting endothelial cells.
  • Targeting TWEAK may offer a therapeutic strategy for HCC.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...